12.07.2015 Views

letopis sazu 2011

letopis sazu 2011

letopis sazu 2011

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Rebula A.: La vigna dell'imperatrice, prevod iz zbirke novel Vinograd rimske cesarice,Mladika, Trst <strong>2011</strong>.Rebula A.: Izbor kolumen iz tednika Družina, Družina, Ljubljana <strong>2011</strong>.Blaž RozmanOBJAVEIrman S., Škarabot M., Muševič I., Rozman B., Božič B.: The use of atomic forcemicroscopy to study the pathological effects of anti-annexin antibodies. J Autoimmun,<strong>2011</strong>, letn. 36, str. 98–105.Huegle T., Schuetz P., Daikeler T., … (Rozman B) …: Late-onset systemic sclerosis-a systematic survey of the EULAR scleroderma trials and research groupdatabase. Rheumatology (Oxford), <strong>2011</strong>, letn. 50, str. 161–165.Avouac J., Fransen J., Walker U. A., … (Rozman B.) …: Preliminary criteria for thevery early diagnosis of systemic sclerosis; results of a Delphi Consensus Studyfrom EULAR Scleroderma trials and Research Group. Ann Rheum Dis, <strong>2011</strong>,letn. 70, str. 476–481.Lakota K., Thallinger G. G., Čučnik S., Božič B., Mrak-Poljšak K., Ambrožič A.,Rozman B., Blinc A., Tomšič M., Sodin-Šemrl S.: Could antibodies againstserum amyloid A function as physiological regulators in humans. Autoimmunity,<strong>2011</strong>, letn. 44, str. 149–158.Kužnik A., Benčina M., Švajger U., Jeras M., Rozman B., Jerala R.: Mechanism ofendosomal TLR inhibition by antimalarial drugs and imidazoquinolines. JImmunol, <strong>2011</strong>, letn. 186, str. 4794–4804.Žigon P., Ambrožič A., Čučnik S., Kveder T., Rozman B., Božič B.: Modifiedphosphatidylserine-dependent antiprothrombine ELISA enables identificationof patients negative for other antiphospholipid antibodies andalso detects low avidity antibodies. Clin Chem Lab Med, <strong>2011</strong>, letn. 49, str.1011–1018.Žager U., Irman Š., Lunder M., Škarabot M., Muševič I., Hodnik V., Anderluh G.,Čučnik S., Kveder T., Rozman B., Božič B.: Immunochemical properties andpathological relevance of anti-beta2-glycoprotein I antibodies of differentavidity. Int. Immunol, <strong>2011</strong>, letn. 23, str. 511–518.Čučnik S., Kveder T., Ulcova G., Swadzba J., Musial J., Valesini G., Avčin T., RozmanB., Božič B.: The avidity of anti-(beta)2-glycoprotein I antibodies in patientswith or without antiphospholipid syndrome: a collaborative study inthe frame of the European forum on antiphospholipid antibodies. Lupus,<strong>2011</strong>, letn. 20, str. 1166–1171.Lakota K., Žigon P., Mrak-Poljšak K., Rozman B., Shoenfeld Y., Sodin-Šemrl S.:Antibodies against acute phase proteins and their functions in the pathogenesisof disese: A collective profile of 25 different antibodies. AutoimmunRev, <strong>2011</strong>, letn. 10, str. 779–789.176

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!